TIMP3 regulates osteosarcoma cell migration, invasion, and chemotherapeutic resistances

作者: Xiu-guo Han , Yan Li , Hui-min Mo , Kang Li , Du Lin

DOI: 10.1007/S13277-015-4757-4

关键词:

摘要: Tissue inhibitors of metalloproteinases (TIMPs) inhibit matrix (MMPs) to limit degradation the extracellular matrix. Low levels TIMP3 have been demonstrated in cancer tissues at advanced clinical stages, with positive distant metastasis and chemotherapeutic resistance. We examined role osteosarcoma (OS) cell invasiveness chemoresistance. was overexpressed or knocked down human OS lines Saos2 MG63. Cell migration invasion capacities were then evaluated using Transwell assays, resistance cisplatin assessed by CCK-8 assay flow cytometry. Real-time PCR western blotting used investigate activation signaling pathways downstream TIMP3. Overexpression inhibited MG63 cells, while knockdown had opposite effect. survival after exposure overexpression both cells. Consistently, downregulation gene expression significantly decreased sensitivity cells treatment. MMP1, MMP2, Bcl-2, Akt1 all downregulated following overexpression, Bax cleaved caspase-3 upregulated. effects on regulation these genes. Taken together, our findings suggest as a new target for inhibition progression

参考文章(33)
Tingting Tang, Lin Du, Wei Yan, Qiming Fan, Bing Tu, Establishment and characterization of a new highly metastatic human osteosarcoma cell line derived from Saos2. International Journal of Clinical and Experimental Pathology. ,vol. 7, pp. 2871- 2882 ,(2014)
Chih-Ya Wang, Jing-Ping Liou, An-Chi Tsai, Mei-Jung Lai, Yi-Min Liu, Hsueh-Yun Lee, Jing-Chi Wang, Shiow-Lin Pan, Che-Ming Teng, A novel action mechanism for MPT0G013, a derivative of arylsulfonamide, inhibits tumor angiogenesis through up-regulation of TIMP3 expression Oncotarget. ,vol. 5, pp. 9838- 9850 ,(2014) , 10.18632/ONCOTARGET.2451
A M Martelli, C Evangelisti, W Chappell, S L Abrams, J Bäsecke, F Stivala, M Donia, P Fagone, F Nicoletti, M Libra, V Ruvolo, P Ruvolo, C R Kempf, L S Steelman, J A McCubrey, Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway Leukemia. ,vol. 25, pp. 1064- 1079 ,(2011) , 10.1038/LEU.2011.46
Xiu-guo Han, Lin Du, Han Qiao, Bing Tu, Yu-gang Wang, An Qin, Ke-rong Dai, Qi-ming Fan, Ting-ting Tang, CXCR1 knockdown improves the sensitivity of osteosarcoma to cisplatin Cancer Letters. ,vol. 369, pp. 405- 415 ,(2015) , 10.1016/J.CANLET.2015.09.002
Hibret A. Adissu, Colin McKerlie, Marco Di Grappa, Paul Waterhouse, Qiang Xu, Hui Fang, Rama Khokha, Geoffrey A. Wood, Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer. The Prostate. ,vol. 75, pp. 1831- 1843 ,(2015) , 10.1002/PROS.23056
Stefano Ferrari, Massimo Serra, An update on chemotherapy for osteosarcoma Expert Opinion on Pharmacotherapy. ,vol. 16, pp. 2727- 2736 ,(2015) , 10.1517/14656566.2015.1102226
Ryuichiro Kimura, Chie Ishikawa, Takayoshi Rokkaku, Ralf Janknecht, Naoki Mori, Phosphorylated c-Jun and Fra-1 induce matrix metalloproteinase-1 and thereby regulate invasion activity of 143B osteosarcoma cells Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. ,vol. 1813, pp. 1543- 1553 ,(2011) , 10.1016/J.BBAMCR.2011.04.008
Abitha Jacob, Rytis Prekeris, The regulation of MMP targeting to invadopodia during cancer metastasis Frontiers in Cell and Developmental Biology. ,vol. 3, pp. 4- 4 ,(2015) , 10.3389/FCELL.2015.00004
Maya Kansara, Michele W. Teng, Mark J. Smyth, David M. Thomas, Translational biology of osteosarcoma Nature Reviews Cancer. ,vol. 14, pp. 722- 735 ,(2014) , 10.1038/NRC3838